Earl Goehring

1.3k total citations
20 papers, 929 citations indexed

About

Earl Goehring is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Economics and Econometrics. According to data from OpenAlex, Earl Goehring has authored 20 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Economics and Econometrics. Recurrent topics in Earl Goehring's work include Atrial Fibrillation Management and Outcomes (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Earl Goehring is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Earl Goehring collaborates with scholars based in United States, Ireland and Canada. Earl Goehring's co-authors include Judith K. Jones, Suellen M. Curkendall, Dewei She, Stephan Lanes, Mary Rose Stang, Stephen P. Motsko, Cornelia Haag‐Molkenteller, Roger R. Dmochowski, Aubrey Manack and Cynthia de Luise and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and The American Journal of Cardiology.

In The Last Decade

Earl Goehring

19 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Earl Goehring United States 9 510 262 165 153 146 20 929
Yukitaka Maruyama Japan 19 177 0.3× 266 1.0× 427 2.6× 27 0.2× 143 1.0× 38 1.4k
Dorota Drożdż Poland 18 131 0.3× 288 1.1× 134 0.8× 52 0.3× 26 0.2× 82 1.2k
Greta Lozano‐Ortega United States 13 86 0.2× 93 0.4× 57 0.3× 96 0.6× 85 0.6× 40 575
Brandon Orr‐Walker New Zealand 18 95 0.2× 111 0.4× 125 0.8× 36 0.2× 46 0.3× 43 1.1k
Aleksander Goch Poland 15 74 0.1× 358 1.4× 34 0.2× 61 0.4× 95 0.7× 79 706
William E. Haley United States 22 341 0.7× 640 2.4× 48 0.3× 15 0.1× 31 0.2× 61 1.3k
Maria Bertilsson Sweden 15 60 0.1× 354 1.4× 90 0.5× 38 0.2× 133 0.9× 28 743
Michael Stechman United Kingdom 18 221 0.4× 181 0.7× 118 0.7× 13 0.1× 20 0.1× 52 1.0k
Rafael Calpena Spain 25 250 0.5× 119 0.5× 240 1.5× 51 0.3× 604 4.1× 112 2.1k
Can Duman Türkiye 16 106 0.2× 247 0.9× 134 0.8× 11 0.1× 27 0.2× 47 931

Countries citing papers authored by Earl Goehring

Since Specialization
Citations

This map shows the geographic impact of Earl Goehring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl Goehring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl Goehring more than expected).

Fields of papers citing papers by Earl Goehring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Earl Goehring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl Goehring. The network helps show where Earl Goehring may publish in the future.

Co-authorship network of co-authors of Earl Goehring

This figure shows the co-authorship network connecting the top 25 collaborators of Earl Goehring. A scholar is included among the top collaborators of Earl Goehring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Earl Goehring. Earl Goehring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebwohl, Mark, John Koo, April W. Armstrong, et al.. (2024). Brodalumab: Six-Year US Pharmacovigilance Report. Dermatology and Therapy. 15(1). 213–222.
2.
Lebwohl, Mark, John Koo, April W. Armstrong, et al.. (2024). Brodalumab: 5-Year US Pharmacovigilance Report. Dermatology and Therapy. 14(5). 1349–1357. 10 indexed citations
3.
Goehring, Earl, Chuntao Wu, Rhonda L. Bohn, et al.. (2021). Risk of interstitial lung disease in patients treated for atrial fibrillation with dronedarone versus other antiarrhythmics. Pharmacoepidemiology and Drug Safety. 30(10). 1353–1359. 4 indexed citations
4.
Lebwohl, Mark, Craig L. Leonardi, April W. Armstrong, et al.. (2021). Three‐year U.S. pharmacovigilance report of brodalumab. Dermatologic Therapy. 34(6). e15105–e15105. 10 indexed citations
5.
Goehring, Earl, Rhonda L. Bohn, John C. Pezzullo, et al.. (2020). Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation. The American Journal of Cardiology. 135. 77–83. 8 indexed citations
6.
Kaplan, Sigal, et al.. (2018). Modafinil and the risk of cardiovascular events: Findings from three US claims databases. Pharmacoepidemiology and Drug Safety. 27(11). 1182–1190. 7 indexed citations
7.
Davis, Kourtney J., David Hinds, Stephen P. Motsko, Earl Goehring, & Judith K. Jones. (2016). Intranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two Continents. Drugs - Real World Outcomes. 3(1). 53–60. 2 indexed citations
8.
9.
Goehring, Earl, Rhonda L. Bohn, John C. Pezzullo, & Judith A. Jones. (2013). REAL-WORLD OUTCOMES FOR DRONEDARONE INITIATORS COMPARED TO OTHER ANTIARRHYTHMIC AGENTS IN THE TREATMENT OF ATRIAL FIBRILLATION IN A LARGE UNITED STATES POPULATION. Journal of the American College of Cardiology. 61(10). E269–E269. 1 indexed citations
10.
Goehring, Earl, et al.. (2012). Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs. Seminars in Arthritis and Rheumatism. 42(2). 119–126. 16 indexed citations
11.
Goehring, Earl, Winifred Werther, Anne E. Fung, et al.. (2012). Hospitalized cardiovascular events in patients with diabetic macular edema. BMC Ophthalmology. 12(1). 11–11. 22 indexed citations
12.
Eisenberg, D., Gregory W. Daniel, Judith K. Jones, et al.. (2012). Validation of a claims‐based diagnostic code for Stevens–Johnson syndrome in a commercially insured population. Pharmacoepidemiology and Drug Safety. 21(7). 760–764. 7 indexed citations
13.
Manack, Aubrey, Stephen P. Motsko, Cornelia Haag‐Molkenteller, et al.. (2010). Epidemiology and healthcare utilization of neurogenic bladder patients in a us claims database. Neurourology and Urodynamics. 30(3). 395–401. 192 indexed citations
14.
Li, Jie, et al.. (2010). Prevalence of pediatric dyslipidemia: comparison of a population‐based claims database to national surveys. Pharmacoepidemiology and Drug Safety. 19(10). 1031–1040. 22 indexed citations
15.
Fung, Anne E., et al.. (2009). Myocardial Infarction and Cerebrovascular Accident in Patients With Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 50(13). 4423–4423. 1 indexed citations
16.
Li, Jie, et al.. (2009). Longitudinal study on pediatric dyslipidemia in population‐based claims database. Pharmacoepidemiology and Drug Safety. 19(1). 90–98. 4 indexed citations
17.
Goehring, Earl, et al.. (2007). Epidemiologic Study of Smell Disturbance in 2 Medical Insurance Claims Populations. Archives of Otolaryngology - Head and Neck Surgery. 133(8). 748–748. 6 indexed citations
18.
Curkendall, Suellen M., Stephan Lanes, Cynthia de Luise, et al.. (2006). Chronic obstructive pulmonary disease severity and cardiovascular outcomes. European Journal of Epidemiology. 21(11). 803–813. 90 indexed citations
19.
Curkendall, Suellen M., Judith K. Jones, Stephan Lanes, et al.. (2005). Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada. Annals of Epidemiology. 16(1). 63–70. 488 indexed citations
20.
Guo, Jeff J., Suellen M. Curkendall, Judith K. Jones, et al.. (2003). Impact of cisapride label changes on codispensing of contraindicated medications. Pharmacoepidemiology and Drug Safety. 12(4). 295–301. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukitaka Maruyama Breakdown of academic impact, for papers by Dorota Drożdż Breakdown of academic impact, for papers by Greta Lozano‐Ortega Breakdown of academic impact, for papers by Brandon Orr‐Walker Breakdown of academic impact, for papers by Aleksander Goch Breakdown of academic impact, for papers by William E. Haley Breakdown of academic impact, for papers by Maria Bertilsson Breakdown of academic impact, for papers by Michael Stechman Breakdown of academic impact, for papers by Rafael Calpena Breakdown of academic impact, for papers by Can Duman
Rankless by CCL
2026